Short-term bisphosphonate treatment reduces serum 25(OH) vitamin D<sub>3</sub> and alters values of parathyroid hormone, pentosidine, and bone metabolic markers.

Kamimura, Mikio; Uchiyama, Shigeharu; Nakamura, Yukio; Ikegami, Shota; Mukaiyama, Keijiro; Kato, Hiroyuki

Short-term bisphosphonate treatment reduces serum 25(OH) vitamin D₃ and alters values of parathyroid hormone, pentosidine, and bone metabolic markers.

Kamimura, Mikio; Uchiyama, Shigeharu; Nakamura, Yukio; Ikegami, Shota; Mukaiyama, Keijiro; Kato, Hiroyuki.

Afiliação

Kamimura M; Center for Osteoporosis and Spinal Disorders, Kamimura Orthopaedic Clinic, Matsumoto, Japan.
Uchiyama S; Department of Orthopaedic Surgery, Shinshu University School of Medicine, Matsumoto, Japan.
Nakamura Y; Department of Orthopaedic Surgery, Shinshu University School of Medicine, Matsumoto, Japan; Department of Orthopedic Surgery, Showa-Inan General Hospital, Komagane, Japan.
Ikegami S; Department of Orthopaedic Surgery, Shinshu University School of Medicine, Matsumoto, Japan.
Mukaiyama K; Department of Orthopaedic Surgery, Shinshu University School of Medicine, Matsumoto, Japan.
Kato H; Department of Orthopaedic Surgery, Shinshu University School of Medicine, Matsumoto, Japan.

Ther Clin Risk Manag ; 13: 161-168, 2017.

Article em En | MEDLINE | ID: mdl-28243105

Palavras-chave

25(OH) vitamin D3; minodronate; parathyroid hormone; pentosidine; risedronate

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Ther Clin Risk Manag Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Ther Clin Risk Manag Ano de publicação: 2017 Tipo de documento: Article